WallStreetZenWallStreetZen

NASDAQ: ACRS
Aclaris Therapeutics Inc Stock Ownership - Who owns Aclaris Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aclaris Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin BalthaserChief Financial Officer2026-03-01677$2.87
$1.94kSell
James LoeropChief Business Officer2026-02-035,937$3.47
$20.60kSell
Kevin BalthaserChief Financial Officer2026-02-036,449$3.47
$22.38kSell
Neal WalkerCEO2026-02-0318,611$3.47
$64.58kSell
James LoeropChief Business Officer2026-02-0110,686$3.51
$37.51kSell
Kevin BalthaserChief Financial Officer2026-02-014,984$3.51
$17.49kSell
Neal WalkerCEO2026-01-029,952$2.88
$28.66kSell
James LoeropChief Business Officer2026-01-026,171$2.88
$17.77kSell
Kevin BalthaserChief Financial Officer2026-01-024,461$2.88
$12.85kSell
Kevin BalthaserChief Financial Officer2026-01-012,250$3.01
$6.77kSell

1 of 2

ACRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACRS insiders and whales buy or sell their stock.

ACRS Shareholders

What type of owners hold Aclaris Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Braden Michael Leonard26.11%28,293,975$106.10MInsider
Bml Capital Management LLC13.15%14,250,000$53.44MInstitution
Vivo Capital LLC8.20%8,888,888$33.33MInstitution
Fmr LLC7.97%8,637,727$32.39MInsider
Blackrock Inc6.28%6,804,841$25.52MInstitution
Vanguard Group Inc6.00%6,502,080$24.38MInstitution
Rock Springs Capital Management LP4.11%4,453,741$16.70MInstitution
Ra Capital Management LP4.01%4,339,299$16.27MInsider
Albert Cha3.87%4,191,397$15.72MInsider
Anand Mehra3.85%4,165,876$15.62MInsider

1 of 3

ACRS vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRS56.41%43.59%Net SellingNet Selling
MYGN89.76%10.24%Net SellingNet Selling
LAB49.23%50.77%Net BuyingNet Buying
FLGT57.16%41.96%Net SellingNet Selling
PRE10.85%3.76%
View Top Diagnostic & Research Stocks

Aclaris Therapeutics Stock Ownership FAQ

Who owns Aclaris Therapeutics?

Aclaris Therapeutics (NASDAQ: ACRS) is owned by 77.29% institutional shareholders, 59.74% Aclaris Therapeutics insiders, and 0.00% retail investors. Braden Michael Leonard is the largest individual Aclaris Therapeutics shareholder, owning 28.29M shares representing 26.11% of the company. Braden Michael Leonard's Aclaris Therapeutics shares are currently valued at $106.10M.

If you're new to stock investing, here's how to buy Aclaris Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.